Anastrozole (Armida) tablets is indicated for postmenopausal women with advanced stage breast cancer who had disease progression following tamoxifen or other antiestrogen treatment. It can be considered using the product when the patient reacts negative with estrogen receptor, but positive with tamoxifen. Adjuvant therapy may be continued for up to 5 years, although the optimum duration is uncertain.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
